[HTML][HTML] COVID-19-associated opportunistic infections: a snapshot on the current reports

A Abdoli, S Falahi, A Kenarkoohi - Clinical and experimental medicine, 2022 - Springer
Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a
complicated challenge, especially among patients with severe disease. In recent studies …

[HTML][HTML] A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA)

S Feys, MP Almyroudi, R Braspenning, K Lagrou… - Journal of Fungi, 2021 - mdpi.com
Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe
fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and …

Coronavirus disease 2019–associated invasive fungal infection

JW Baddley, GR Thompson III… - Open forum …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …

[HTML][HTML] Invasive fungal infections complicating COVID-19: a narrative review

G Casalini, A Giacomelli, A Ridolfo, C Gervasoni… - Journal of Fungi, 2021 - mdpi.com
Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …

[HTML][HTML] First report from the German COVID-19 autopsy registry

S von Stillfried, RD Bülow, R Röhrig, P Boor… - The Lancet Regional …, 2022 - thelancet.com
Background Autopsies are an important tool in medicine, dissecting disease
pathophysiology and causes of death. In COVID-19, autopsies revealed eg, the effects on …

[HTML][HTML] Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients

R Leistner, L Schroeter, T Adam, D Poddubnyy… - Critical Care, 2022 - Springer
Purpose Corticosteroids, in particular dexamethasone, are one of the primary treatment
options for critically ill COVID-19 patients. However, there are a growing number of cases …

[HTML][HTML] Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis

WH Chong, BK Saha, KP Neu - Infection, 2022 - Springer
Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19
patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis …

[HTML][HTML] Defining COVID-19–associated pulmonary aspergillosis: systematic review and meta-analysis

RM Kariyawasam, TC Dingle, BE Kula… - Clinical Microbiology …, 2022 - Elsevier
Background Pulmonary aspergillosis may complicate coronavirus disease 2019 (COVID-19)
and contribute to excess mortality in intensive care unit (ICU) patients. The disease is poorly …

[HTML][HTML] Prevalence of COVID-19-associated pulmonary aspergillosis: critical review and conclusions

M Egger, L Bussini, M Hoenigl, M Bartoletti - Journal of Fungi, 2022 - mdpi.com
First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Navigating the uncertainties of COVID-19–associated aspergillosis: a comparison with influenza-associated aspergillosis

F Lamoth, RE Lewis, TJ Walsh… - The Journal of …, 2021 - academic.oup.com
Invasive pulmonary aspergillosis (IPA) is increasingly recognized as a life-threatening
superinfection of severe respiratory viral infections, such as influenza. The pandemic of …